
TSI GROUP CO., LTD. — Investor Relations & Filings
TSI Group Co., Ltd. is a global developer and manufacturer of functional ingredients and finished dosage forms for the dietary supplement, pharmaceutical, and food and beverage sectors. The company specializes in the research, development, and large-scale production of high-quality bioactive compounds. Key product categories include joint health ingredients such as glucosamine and chondroitin, as well as proprietary muscle health and metabolic health solutions like HMB and PEAK ATP. TSI Group maintains advanced manufacturing facilities and quality control systems to ensure compliance with international standards. The organization focuses on providing science-based ingredients supported by clinical research to global brand owners and manufacturers. Its core capabilities span from raw material sourcing and chemical synthesis to specialized formulation and finished product manufacturing.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 技源集团关于2026年度向银行申请银行授信额度的公告 | 2026-04-27 | Chinese | |
| 技源集团2025年度内部控制评价报告 | 2026-04-27 | Chinese | |
| 董事和高级管理人员薪酬管理制度 | 2026-04-27 | Chinese | |
| 技源集团股份有限公司关于使用闲置募集资金进行现金管理赎回的公告 | 2026-04-20 | Chinese | |
| 技源集团股份有限公司关于使用闲置募集资金进行现金管理赎回的公告 | 2026-04-01 | Chinese | |
| 技源集团股份有限公司关于使用闲置募集资金进行现金管理赎回的公告 | 2026-03-30 | Chinese |
Browse filings by year
2 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 39593572 | 技源集团关于2026年度向银行申请银行授信额度的公告 | 2026-04-27 | Chinese | ||
| 39593570 | 技源集团2025年度内部控制评价报告 | 2026-04-27 | Chinese | ||
| 39593569 | 董事和高级管理人员薪酬管理制度 | 2026-04-27 | Chinese | ||
| 39593562 | 技源集团股份有限公司关于使用闲置募集资金进行现金管理赎回的公告 | 2026-04-20 | Chinese | ||
| 39593557 | 技源集团股份有限公司关于使用闲置募集资金进行现金管理赎回的公告 | 2026-04-01 | Chinese | ||
| 39593551 | 技源集团股份有限公司关于使用闲置募集资金进行现金管理赎回的公告 | 2026-03-30 | Chinese | ||
| 39593547 | 技源集团股份有限公司关于使用闲置募集资金进行现金管理赎回的公告 | 2026-03-16 | Chinese | ||
| 39593538 | 技源集团股份有限公司关于使用闲置募集资金进行现金管理赎回的公告 | 2026-02-27 | Chinese | ||
| 39593534 | 技源集团股份有限公司关于使用闲置募集资金进行现金管理赎回的公告 | 2026-02-26 | Chinese | ||
| 39593529 | 技源集团股份有限公司关于使用闲置募集资金进行现金管理赎回的公告 | 2026-02-25 | Chinese | ||
| 39593525 | 技源集团股份有限公司关于拟注销和开立募集资金专户并签订三方监管协议的公告 | 2026-02-12 | Chinese | ||
| 39593523 | 技源集团股份有限公司关于使用闲置募集资金进行现金管理赎回的公告 | 2026-02-10 | Chinese | ||
| 39593518 | 技源集团股份有限公司关于使用闲置募集资金进行现金管理赎回的公告 | 2026-02-09 | Chinese | ||
| 39593514 | 技源集团股份有限公司关于使用闲置募集资金进行现金管理赎回的公告 | 2026-02-02 | Chinese | ||
| 39593508 | 国浩律师(上海)事务所关于技源集团股份有限公司2026年第一次临时股东会的法律意见书 | 2026-01-30 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
TSI GROUP CO., LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/57547/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=57547 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=57547 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=57547 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 57547}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for TSI GROUP CO., LTD. (id: 57547)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.